Who Exports Metoclopramide from India — 321 Suppliers Behind a $22.7M Market
India's metoclopramide export market is supplied by 321 active exporters who collectively shipped $22.7M across 2,053 shipments. IPCA LABORATORIES LIMITED leads with a 48.1% market share, followed by AVET LIFESCIENCES PRIVATE LIMITED and BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED. The top 5 suppliers together control 72.9% of total export value, reflecting a concentrated market structure.
Top Metoclopramide Exporters from India — Ranked by Export Value
IPCA LABORATORIES LIMITED is the leading metoclopramide exporter from India, holding a 48.1% share of the $22.7M market across 2,053 shipments from 321 exporters. The top 5 suppliers — IPCA LABORATORIES LIMITED, AVET LIFESCIENCES PRIVATE LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, MAAN PHARMACEUTICALS LTD, LINCOLN PHARMACEUTICALS LTD — collectively control 72.9% of total export value, indicating a highly concentrated market. Individual shares are: IPCA LABORATORIES LIMITED (48.1%), AVET LIFESCIENCES PRIVATE LIMITED (12.6%), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED (4.2%), MAAN PHARMACEUTICALS LTD (4.0%), LINCOLN PHARMACEUTICALS LTD (3.9%).
Top Metoclopramide Exporters from India
Ranked by export value · 321 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED METOCLOPRAMIDE HYDROCHLORIDE10MG FILM COATED TABLETSHARMLESS MEDICINES:APO-METOCLOPRAMIDE 10MG TABLETSMETOCLOPRAMIDE INJECTION BP 10MG/2ML (PE | $10.9M | 8 | 48.1% |
| 2 | AVET LIFESCIENCES PRIVATE LIMITED MEDICINES - METOCLOPRAMIDE INJ. USP 10MG/2ML AVET SNMETOCLOPRAMIDE 10MG/2ML SSOL 25X2ML GVL | $2.9M | 1 | 12.6% |
| 3 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED HARMLESS MEDICINES:APO-METOCLOPRAMIDE 10MG TABLETSHARMLESS MEDICINES MAR-METOCLOPRAMIDEHARMLESS MEDICINES : MAR-METOCLOPRAMIDE UNIT RATE CA | $947.6K | 6 | 4.2% |
| 4 | MAAN PHARMACEUTICALS LTD METOP AMPOULMAXOMET TABLET,METOCLOPRAMIDE HYDROCHLORIDE BP, | $918.0K | 3 | 4.0% |
| 5 | LINCOLN PHARMACEUTICALS LTD METOCLOPRAMIDE INJECTION BP 10MG/2ML (PEMETOCLOPRAMIDE INJECTION BP 5MG ML 2MLAMPOULEBABYNORM 0.2MG 15ML DROP METOCLOPRAMIDE | $887.8K | 5 | 3.9% |
| 6 | ADCOCK INGRAM LIMITED ADCO-CONTROMET TABLETS (METOCLOPRAMIDE HMAXOLON METOCLOPRAMIDE INJ 2ML | $536.0K | 1 | 2.4% |
| 7 | SCOTT EDIL PHARMACIA LIMITED METOP AMPOULADCO-CONTROMET TABLETS (METOCLOPRAMIDE HBABYNORM 0.2MG 15ML DROP METOCLOPRAMIDE | $343.9K | 9 | 1.5% |
| 8 | CADILA PHARMACEUTICALS LIMITED ADCO-CONTROMET TABLETS (METOCLOPRAMIDE HMAXOLON METOCLOPRAMIDE INJ 2ML | $336.3K | 1 | 1.5% |
| 9 | GLAND PHARMA LIMITED METOCLOPRAMIDE INJECTION BP 5MG ML 2MLAMPOULEMETOCLOPRAMIDE INJECTION BP 5MG/ML,2ML AMETOCLOPRAMIDE TABLETS-BP-10MG[11840PAC | $286.0K | 3 | 1.3% |
| 10 | MAIVA PHARMA PRIVATE LIMITED HARMLESS MEDICINES:APO-METOCLOPRAMIDE 10MG TABLETSHARMLESS MEDICINES MAR-METOCLOPRAMIDEHARMLESS MEDICINES : MAR-METOCLOPRAMIDE UNIT RATE CA | $229.4K | 3 | 1.0% |
| 11 | INTAS PHARMACEUTICALS LIMITED PHARMA DRUG&MED:METOCLOPRAMIDE ORIFARM 1 | $215.4K | 3 | 0.9% |
| 12 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED ADCO-CONTROMET TABLETS (METOCLOPRAMIDE HMAXOLON METOCLOPRAMIDE INJ 2ML | $176.3K | 11 | 0.8% |
| 13 | ACULIFE HEALTHCARE PRIVATE LIMITED | $167.1K | 2 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Metoclopramide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| IPCA LABORATORIES LIMITED | Not Listed | Yes | Yes | Not Listed | Certified by WHO-GMP and EU GMP; no FDA listing found. |
| AVET LIFESCIENCES PRIVATE LIMITED | Approved | Not Listed | Not Listed | Not Listed | FDA-approved for multiple drugs, including Metoclopramide Hydrochloride. |
| INTAS PHARMACEUTICALS LIMITED | Warning Letter, December | Not Listed | Yes | Not Listed | Received FDA warning letter in December 2022; holds EU GMP certification. |
| ALEMBIC PHARMACEUTICALS LIMITED | Approved | Not Listed | Not Listed | Not Listed | Received multiple FDA approvals between 2024 and 2025. |
TransData Nexus reviewed the regulatory standing of 4 leading Metoclopramide exporters from India. 2 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Metoclopramide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for Active Pharmaceutical Ingredients (APIs) production. The city's pharmaceutical landscape is bolstered by the presence of major companies like Natco Pharma, which specializes in APIs and finished dosage formulations. Hyderabad's strategic location and well-established infrastructure make it a significant contributor to India's pharmaceutical exports.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts prominent companies such as Torrent Pharmaceuticals and Intas Pharmaceuticals, both headquartered in Ahmedabad. These firms are integral to the production and export of various pharmaceutical products, including Metoclopramide formulations. Gujarat's robust pharmaceutical infrastructure and favorable business environment have solidified its status as a formulations hub.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceutical products. Mumbai, being a major commercial center, is home to leading pharmaceutical companies like Sun Pharmaceutical Industries and Unichem Laboratories. These companies play a significant role in the manufacturing and export of Metoclopramide, leveraging the region's extensive port facilities and logistical advantages to access international markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. This area has attracted numerous pharmaceutical companies, contributing to the production of various drugs, including Metoclopramide. The region's growth underscores the impact of policy-driven incentives on pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: While IPCA Laboratories Limited accounts for 48.1% of Metoclopramide exports, engaging with other suppliers such as AVET Lifesciences and Baxter Pharmaceuticals can mitigate supply chain risks.
- Leverage Regional Strengths: Utilize the bulk drug production capabilities of Hyderabad for API sourcing and the formulation expertise of the Ahmedabad-Vadodara cluster for finished products.
- Optimize Logistics: Capitalize on the export infrastructure of the Mumbai-Thane-Raigad region to streamline international shipments of Metoclopramide.
- Monitor Policy Changes: Stay informed about government incentives and regulatory developments in regions like Baddi-Nalagarh to take advantage of cost-saving opportunities in manufacturing.
By strategically engaging with these pharmaceutical clusters and suppliers, companies can enhance the efficiency and resilience of their Metoclopramide supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Metoclopramide exporters from India
IPCA LABORATORIES LIMITED — IPCA acquires Aleor Dermaceuticals for full ownership
In March 2022, IPCA LABORATORIES LIMITED acquired the remaining 50% stake in Aleor Dermaceuticals Ltd., making it a wholly-owned subsidiary. This acquisition aimed to enhance IPCA's capabilities in dermatology and expand its product portfolio.
Impact: The acquisition is expected to strengthen IPCA's manufacturing and R&D capabilities, potentially increasing Metoclopramide production and export capacity.
AVET LIFESCIENCES PRIVATE LIMITED — Avet Lifesciences acquires Punishka Healthcare to expand injectable manufacturing
In November 2021, AVET LIFESCIENCES PRIVATE LIMITED acquired Punishka Healthcare, a company specializing in injectable medicines. This strategic move aimed to bolster Avet's manufacturing capacity and product offerings in the injectable segment.
Impact: The acquisition is likely to enhance Avet's production capabilities, potentially leading to increased Metoclopramide exports.
IPCA LABORATORIES LIMITED — IPCA acquires Orit Laboratories to strengthen U.S. presence
In 2017, IPCA LABORATORIES LIMITED acquired Orit Laboratories LLC, a U.S.-based pharmaceutical company. This acquisition aimed to enhance IPCA's presence in the U.S. market and expand its product portfolio.
Impact: The acquisition is expected to strengthen IPCA's manufacturing and R&D capabilities, potentially increasing Metoclopramide production and export capacity.
Common Questions — Metoclopramide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which metoclopramide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, IPCA LABORATORIES LIMITED leads with 102 recorded shipments worth $10.9M. AVET LIFESCIENCES PRIVATE LIMITED (30 shipments) and BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED (35 shipments) are also established high-volume exporters.
Q How many metoclopramide manufacturers are there in India?
India has 321 active metoclopramide exporters with a combined export market of $22.7M across 2,053 shipments to 126 countries. The top 5 suppliers hold 72.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for metoclopramide from India?
Average FOB unit price: $14.22 per unit, ranging from $0.00 to $12052.10. Average shipment value: $11.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 321 verified Indian exporters of Metoclopramide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,053 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 126 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,053 Verified Shipments
321 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists